{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:55:56Z","timestamp":1793336156723,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psychres.2025.116691","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:03:48Z","timestamp":1755497028000},"page":"116691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorder"],"prefix":"10.1016","volume":"352","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1325-1787","authenticated-orcid":false,"given":"Sipan","family":"Haikazian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kratiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-7139","authenticated-orcid":false,"given":"Cristian-Daniel","family":"Llach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6641-0057","authenticated-orcid":false,"given":"Diana K.","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D.","family":"Di Luch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Aan Het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2025.116691_bib0002","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/bs12060195","article-title":"Repetitive transcranial magnetic stimulation for the treatment of resistant depression: a scoping review","volume":"12","author":"Adu","year":"2022","journal-title":"Behav. Sci."},{"issue":"7","key":"10.1016\/j.psychres.2025.116691_bib0003","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.4088\/JCP.17f11738","article-title":"Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?","volume":"78","author":"Andrade","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0004","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"03","key":"10.1016\/j.psychres.2025.116691_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.13r08722","article-title":"Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration","volume":"75","author":"Borges","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0006","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jad.2024.04.039","article-title":"Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: a systematic review and meta-analysis","volume":"356","author":"Calder","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2025.116691_bib0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tins.2012.12.010","article-title":"Neuronal plasticity and antidepressant actions","volume":"36","author":"Castr\u00e9n","year":"2013","journal-title":"Trend. Neurosci."},{"issue":"10","key":"10.1016\/j.psychres.2025.116691_bib0008","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41386-019-0365-0","article-title":"Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial","volume":"44","author":"Costi","year":"2019","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.psychres.2025.116691_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0000000000001149","article-title":"Metabolic syndrome rather than body mass index is associated with treatment response to ketamine infusions","volume":"40","author":"Dale","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMa Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2025.116691_bib0011","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2023.12.038","article-title":"The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: a post-hoc analysis of pooled real-world data","volume":"348","author":"d\u2019Andrea","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.psychres.2025.116691_bib0013","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/bdi.13284","article-title":"Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression","volume":"25","author":"Fancy","year":"2023","journal-title":"Bipolar. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0015","first-page":"126","article-title":"A methodology for conducting retrospective chart review research in child and adolescent psychiatry","volume":"15","author":"Gearing","year":"2006","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0016","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2025.116691_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"AJP"},{"key":"10.1016\/j.psychres.2025.116691_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.992624","article-title":"Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: a retrospective study of off-label, at-home use","volume":"13","author":"Hassan","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116691_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.2018.257","article-title":"Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2025.116691_bib0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"31","key":"10.1016\/j.psychres.2025.116691_bib0021","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.12998\/wjcc.v9.i31.9350","article-title":"Major depressive disorder: validated treatments and future challenges","volume":"9","author":"Karrouri","year":"2021","journal-title":"World J. Clin. Case."},{"issue":"6","key":"10.1016\/j.psychres.2025.116691_bib0022","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"15","key":"10.1016\/j.psychres.2025.116691_bib0023","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1017\/S0033291720003505","article-title":"Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis","volume":"51","author":"Kishi","year":"2021","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.psychres.2025.116691_bib0024","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","article-title":"Linking molecules to mood: new insight into the biology of depression","volume":"167","author":"Krishnan","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jad.2025.01.054","article-title":"Hepatic adverse events associated with ketamine and esketamine: a population-based disproportionality analysis","volume":"374","author":"Kwan","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.psychres.2025.116691_bib0026","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/07067437251337603","volume":"70","author":"Lam","year":"2025","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0027","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2021.12.084","article-title":"Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: a naturalistic follow-up study","volume":"300","author":"Li","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116691_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.13296","article-title":"Treating bipolar depression with esketamine: safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression","author":"Martinotti","year":"2023","journal-title":"Bipolar. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2025.116691_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145709000169","article-title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","volume":"13","author":"Mathew","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S1092852916000559","article-title":"Mixed features and mixed states in psychiatry: from calculus to geometry","volume":"22","author":"McIntyre","year":"2017","journal-title":"CNS. Spectr."},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0031","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"10265","key":"10.1016\/j.psychres.2025.116691_bib0032","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.psychres.2025.116691_bib0033","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bdi.12941","article-title":"The effectiveness of ketamine on anxiety, irritability, and agitation: implications for treating mixed features in adults with major depressive or bipolar disorder","volume":"22","author":"McIntyre","year":"2020","journal-title":"Bipolar. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2025.116691_bib0034","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"AJP"},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2025.116691_bib0036","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"AJP"},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0037","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12859","article-title":"Maintaining rapid antidepressant effects following ketamine infusion: a major unmet need","volume":"81","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116691_bib0038","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"AJP"},{"issue":"12","key":"10.1016\/j.psychres.2025.116691_bib0039","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"AJP"},{"issue":"5","key":"10.1016\/j.psychres.2025.116691_bib0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0041","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jad.2020.07.089","article-title":"Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: a retrospective chart review","volume":"276","author":"Sakurai","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116691_bib0042","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2013.10.036","article-title":"Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression","volume":"155","author":"Shiroma","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2025.116691_bib0043","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2025.116691_bib0044","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","article-title":"Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability","volume":"9","author":"Smith-Apeldoorn","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5498\/wjp.v4.i3.49","article-title":"Conducting clinical research in community mental health settings: opportunities and challenges","volume":"4","author":"Tcheremissine","year":"2014","journal-title":"World J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116691_bib0046","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3892\/etm.2021.10716","article-title":"Efficacy of electroconvulsive therapy as a potential first\u2011choice treatment in treatment\u2011resistant depression (Review)","volume":"22","author":"Trifu","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116691_bib0047","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0048","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116691_bib0049","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using Ketamine as a clinical treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116691_bib0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jad.2024.01.142","article-title":"A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): a systematic review","volume":"350","author":"Wong","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116691_bib0051","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis","volume":"134","author":"Xiong","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2025.116691_bib0052","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Health"},{"issue":"11","key":"10.1016\/j.psychres.2025.116691_bib0053","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of Ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2025.116691_bib0054","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116691_bib0055","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:46:27Z","timestamp":1779943587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0165178125003397"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116691","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116691"}}